Metrics as of 10/16/2026, 11:30 AM (Berlin time), refresh in progress.
Surgery Partners Stock
Surgery Partners, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- J. Eric Evans
- Employees
- 16,000
- Market cap
- $1.9 B
- IPO
- 30/09/2015
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States within the healthcare sector. The company is headquartered in Brentwood, Tennessee, and functions through two primary segments, which are Surgical Facility Services and Ancillary…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Surgery Partners stock: price history
1D
-0.4%
1W
+8.3%
1M
+8.2%
6M
+10.0%
YTD
-4.4%
1Y
-30.0%
2Y
-53.7%
5Y
-64.0%
10Y
-26.4%
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~30% stronger price swings than usual
Ask the agents about Surgery Partners
Analyst assessment of Surgery Partners
PRICE TARGET LOW
US$17.00
CONSENSUS
US$18.00
MEDIAN
US$18.00
PRICE TARGET HIGH
US$19.00
0
STRONG BUY
14
BUY
8
HOLD
0
SELL
0
STRONG SELL
22
TOTAL · Buy
As of: 30/09/2026
Surgery Partners stock metrics
P/E
-21.41
P/B
1.14
EV/EBITDA
6.05
RETURN ON EQUITY
-0.9%
NET MARGIN
-1.8%
DEBT/EQUITY
2.4
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
59.6%
FLOAT SHARES
78,002,254
AVG. DAILY VOLUME (30D)
2,037,449
Insider transactions (SEC)
DeLuca Teresa
HENDRIX BLAIR E
DeLuca Teresa
Dean Lloyd H
ADLERZ CLIFFORD G
Institutional holders
Comparable stocks
Frequently asked questions about Surgery Partners stock
What does Surgery Partners do?
Surgery Partners, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is J. Eric Evans, the company employs around 16,000 people.
The IPO was on 30/09/2015; the stock trades on NASDAQ under the ticker SGRY.
What do analysts say about Surgery Partners stock?
22 analysts rate the stock, the consensus is Buy (as of 30/09/2026).
The average price target is US$18.00, ranging from US$17.00 to US$19.00, with a median of US$18.00.
This is an external assessment, not a statement by Market Jury.
When does Surgery Partners report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 30% stronger than usual.
Does Surgery Partners pay a dividend?
No, Surgery Partners currently does not pay a dividend.
Which stocks are comparable to Surgery Partners?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Surgery Partners stock analyzed?
Clicking "Analyze stock" lets five strategies assess Surgery Partners against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.